Takeda Intends to Rapidly Initiate the First Global Phase 3 Trials of TAK-861, an Oral Orexin Agonist, in Narcolepsy Type 1 in First Half of Fiscal Year 2024
− Primary and Key Secondary Endpoints Were Met in Narcolepsy Type 1 Phase 2b Trial…
− Primary and Key Secondary Endpoints Were Met in Narcolepsy Type 1 Phase 2b Trial…
PERTH, Australia--(BUSINESS WIRE)--Australia’s two largest iron ore producers and its biggest steelmaker have partnered in…
The largest annual optics and photonics event of the year, which includes the rapidly growing…
DUBLIN--(BUSINESS WIRE)--The "Idiopathic Pulmonary Fibrosis (IPF) Patient Pool Analysis, Market Size and Market Forecast APAC…
THE WOODLANDS, Texas--(BUSINESS WIRE)--Chevron Phillips Chemical announced today that Steve Prusak, currently senior vice president,…
Leading microfinance bank gains proactive mobile app protection and valuable app insights to further strengthen…
Motorola Solutions to leverage Google Cloud to help accelerate innovation for public safety and enterprise…
BESANÇON, France--(BUSINESS WIRE)--Pixee Medical, world leader in augmented reality navigation technologies for orthopedic surgery, takes…
Record-Breaking Q4 Revenue and Full-Year 2023 Revenue and Operating Income THE FINALS Season 2 Coming…
DUBLIN--(BUSINESS WIRE)--The "Global Tissue Engineering Market by Product (Scaffolds (Collagen, Stem Cell), Tissue Grafts (Allograft,…